Log In
BCIQ
Print this Print this
 

HM23

  Manage Alerts
Collapse Summary General Information
Company Suzhou Stainwei Biotech Inc.
DescriptionHM23 (mAb)
Molecular Target
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPreclinical
Standard IndicationSolid tumors
Indication DetailsTreat solid tumors
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today